PlasmaBound, a Dublin, Ireland-based developer of a novel surface treatment technology, closed a €1.1m funding round.
The round was led by the Atlantic Bridge University Fund, with participation from Enterprise Ireland, and a number of private investors. Brendan Cremen will join the PlasmaBound Board of Directors on behalf of Atlantic Bridge.
PlasmaBound has developed patented technology, called controlled polymer ablation (CPA), which enables global manufacturing industries to reduce product weight and meet fuel efficiency and carbon emissions requirements. The technology enables global players in the automotive, aerospace/space and wind turbine industries to achieve lightweighting goals with fully automated workstreams.
Headquartered at NovaUCD, the Centre for New Ventures and Entrepreneurs, the company was co-founded in 2017 by Dr James Nicholas Barry, Alan Barry and Xavier Montibert as a spin-out from the University College Dublin (UCD) – College of Engineering and Architecture, following the completion of Enterprise Ireland Commercialisation Funding. The company is also an Enterprise Ireland High-Potential Start-Up.
FinSMEs
24/06/2020